Karen Anderson, M.D., Ph.D.

Associate Professor, School of Life Sciences
The Biodesign Institute, Arizona State University (ASU)

Dr. Anderson obtained her MD and Ph.D. at Duke University, and her clinical hematology/oncology training at the Dana Farber Cancer Institute in Boston, where she was a faculty member until 2011. She is currently a translational research scientist and Associate Professor at the Biodesign Institute at Arizona State University and the Mayo Clinic Arizona. She has extensive experience in the clinical translation of novel experimental diagnostics and therapeutics for cancer. Her laboratory has developed novel biomarkers for the early detection of breast, ovarian cancer, and HPV-associated cancers. She is the co-chair of the NCI/Early Detection Research Network Breast/Gyn collaborative group and is the Principal Investigator of a national study of biomarkers for triple negative breast cancer.